CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: ADAPTOGENS MARKET, BY SOURCE
4.1 Overview
4.1.1 Market size and forecast
4.2 Ashwagandha
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Ginseng
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Astragalus
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Holy Basils
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
4.6 Rhodiola Roseas
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market analysis by country
4.7 Schisandra
4.7.1 Key market trends, growth factors and opportunities
4.7.2 Market size and forecast, by region
4.7.3 Market analysis by country
4.8 Adaptogenic mushrooms
4.8.1 Key market trends, growth factors and opportunities
4.8.2 Market size and forecast, by region
4.8.3 Market analysis by country
4.9 Others
4.9.1 Key market trends, growth factors and opportunities
4.9.2 Market size and forecast, by region
4.9.3 Market analysis by country
CHAPTER 5: ADAPTOGENS MARKET, BY END USE
5.1 Overview
5.1.1 Market size and forecast
5.2 Powder
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Capsules
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Teas and Beverages
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Others
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
CHAPTER 6: ADAPTOGENS MARKET, BY APPLICATION
6.1 Overview
6.1.1 Market size and forecast
6.2 Food and Beverages
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Dietary and sports supplements
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Cosmetics
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Animal Feed
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country
6.6 Pharmaceutical
6.6.1 Key market trends, growth factors and opportunities
6.6.2 Market size and forecast, by region
6.6.3 Market analysis by country
CHAPTER 7: ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL
7.1 Overview
7.1.1 Market size and forecast
7.2 Business to Business
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market analysis by country
7.3 Business to Consumer
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market analysis by country
7.3.4 Business to Consumer Adaptogens Market by Sales channel
7.3.4.1 Supermarket and hypermarket Market size and forecast, by region
7.3.4.2 Specialty store Market size and forecast, by region
7.3.4.3 Pharmacies and drug stores Market size and forecast, by region
7.3.4.4 Others Market size and forecast, by region
CHAPTER 8: ADAPTOGENS MARKET, BY REGION
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key trends and opportunities
8.2.2 North America Market size and forecast, by Source
8.2.3 North America Market size and forecast, by End Use
8.2.4 North America Market size and forecast, by Application
8.2.5 North America Market size and forecast, by Distribution Channel
8.2.5.1 North America Business to Consumer Adaptogens Market by Sales channel
8.2.6 North America Market size and forecast, by country
8.2.6.1 U.S.
8.2.6.1.1 Market size and forecast, by Source
8.2.6.1.2 Market size and forecast, by End Use
8.2.6.1.3 Market size and forecast, by Application
8.2.6.1.4 Market size and forecast, by Distribution Channel
8.2.6.2 Canada
8.2.6.2.1 Market size and forecast, by Source
8.2.6.2.2 Market size and forecast, by End Use
8.2.6.2.3 Market size and forecast, by Application
8.2.6.2.4 Market size and forecast, by Distribution Channel
8.2.6.3 Mexico
8.2.6.3.1 Market size and forecast, by Source
8.2.6.3.2 Market size and forecast, by End Use
8.2.6.3.3 Market size and forecast, by Application
8.2.6.3.4 Market size and forecast, by Distribution Channel
8.3 Europe
8.3.1 Key trends and opportunities
8.3.2 Europe Market size and forecast, by Source
8.3.3 Europe Market size and forecast, by End Use
8.3.4 Europe Market size and forecast, by Application
8.3.5 Europe Market size and forecast, by Distribution Channel
8.3.5.1 Europe Business to Consumer Adaptogens Market by Sales channel
8.3.6 Europe Market size and forecast, by country
8.3.6.1 UK
8.3.6.1.1 Market size and forecast, by Source
8.3.6.1.2 Market size and forecast, by End Use
8.3.6.1.3 Market size and forecast, by Application
8.3.6.1.4 Market size and forecast, by Distribution Channel
8.3.6.2 Italy
8.3.6.2.1 Market size and forecast, by Source
8.3.6.2.2 Market size and forecast, by End Use
8.3.6.2.3 Market size and forecast, by Application
8.3.6.2.4 Market size and forecast, by Distribution Channel
8.3.6.3 Germany
8.3.6.3.1 Market size and forecast, by Source
8.3.6.3.2 Market size and forecast, by End Use
8.3.6.3.3 Market size and forecast, by Application
8.3.6.3.4 Market size and forecast, by Distribution Channel
8.3.6.4 France
8.3.6.4.1 Market size and forecast, by Source
8.3.6.4.2 Market size and forecast, by End Use
8.3.6.4.3 Market size and forecast, by Application
8.3.6.4.4 Market size and forecast, by Distribution Channel
8.3.6.5 Spain
8.3.6.5.1 Market size and forecast, by Source
8.3.6.5.2 Market size and forecast, by End Use
8.3.6.5.3 Market size and forecast, by Application
8.3.6.5.4 Market size and forecast, by Distribution Channel
8.3.6.6 The Netherlands
8.3.6.6.1 Market size and forecast, by Source
8.3.6.6.2 Market size and forecast, by End Use
8.3.6.6.3 Market size and forecast, by Application
8.3.6.6.4 Market size and forecast, by Distribution Channel
8.3.6.7 Switzerland
8.3.6.7.1 Market size and forecast, by Source
8.3.6.7.2 Market size and forecast, by End Use
8.3.6.7.3 Market size and forecast, by Application
8.3.6.7.4 Market size and forecast, by Distribution Channel
8.3.6.8 Rest of Europe
8.3.6.8.1 Market size and forecast, by Source
8.3.6.8.2 Market size and forecast, by End Use
8.3.6.8.3 Market size and forecast, by Application
8.3.6.8.4 Market size and forecast, by Distribution Channel
8.4 Asia-Pacific
8.4.1 Key trends and opportunities
8.4.2 Asia-Pacific Market size and forecast, by Source
8.4.3 Asia-Pacific Market size and forecast, by End Use
8.4.4 Asia-Pacific Market size and forecast, by Application
8.4.5 Asia-Pacific Market size and forecast, by Distribution Channel
8.4.5.1 Asia-Pacific Business to Consumer Adaptogens Market by Sales channel
8.4.6 Asia-Pacific Market size and forecast, by country
8.4.6.1 China
8.4.6.1.1 Market size and forecast, by Source
8.4.6.1.2 Market size and forecast, by End Use
8.4.6.1.3 Market size and forecast, by Application
8.4.6.1.4 Market size and forecast, by Distribution Channel
8.4.6.2 Japan
8.4.6.2.1 Market size and forecast, by Source
8.4.6.2.2 Market size and forecast, by End Use
8.4.6.2.3 Market size and forecast, by Application
8.4.6.2.4 Market size and forecast, by Distribution Channel
8.4.6.3 India
8.4.6.3.1 Market size and forecast, by Source
8.4.6.3.2 Market size and forecast, by End Use
8.4.6.3.3 Market size and forecast, by Application
8.4.6.3.4 Market size and forecast, by Distribution Channel
8.4.6.4 South Korea
8.4.6.4.1 Market size and forecast, by Source
8.4.6.4.2 Market size and forecast, by End Use
8.4.6.4.3 Market size and forecast, by Application
8.4.6.4.4 Market size and forecast, by Distribution Channel
8.4.6.5 Australia
8.4.6.5.1 Market size and forecast, by Source
8.4.6.5.2 Market size and forecast, by End Use
8.4.6.5.3 Market size and forecast, by Application
8.4.6.5.4 Market size and forecast, by Distribution Channel
8.4.6.6 Indonesia
8.4.6.6.1 Market size and forecast, by Source
8.4.6.6.2 Market size and forecast, by End Use
8.4.6.6.3 Market size and forecast, by Application
8.4.6.6.4 Market size and forecast, by Distribution Channel
8.4.6.7 Thailand
8.4.6.7.1 Market size and forecast, by Source
8.4.6.7.2 Market size and forecast, by End Use
8.4.6.7.3 Market size and forecast, by Application
8.4.6.7.4 Market size and forecast, by Distribution Channel
8.4.6.8 Rest of Asia-Pacific
8.4.6.8.1 Market size and forecast, by Source
8.4.6.8.2 Market size and forecast, by End Use
8.4.6.8.3 Market size and forecast, by Application
8.4.6.8.4 Market size and forecast, by Distribution Channel
8.5 LAMEA
8.5.1 Key trends and opportunities
8.5.2 LAMEA Market size and forecast, by Source
8.5.3 LAMEA Market size and forecast, by End Use
8.5.4 LAMEA Market size and forecast, by Application
8.5.5 LAMEA Market size and forecast, by Distribution Channel
8.5.5.1 LAMEA Business to Consumer Adaptogens Market by Sales channel
8.5.6 LAMEA Market size and forecast, by country
8.5.6.1 Latin America
8.5.6.1.1 Market size and forecast, by Source
8.5.6.1.2 Market size and forecast, by End Use
8.5.6.1.3 Market size and forecast, by Application
8.5.6.1.4 Market size and forecast, by Distribution Channel
8.5.6.2 Middle East
8.5.6.2.1 Market size and forecast, by Source
8.5.6.2.2 Market size and forecast, by End Use
8.5.6.2.3 Market size and forecast, by Application
8.5.6.2.4 Market size and forecast, by Distribution Channel
8.5.6.3 Africa
8.5.6.3.1 Market size and forecast, by Source
8.5.6.3.2 Market size and forecast, by End Use
8.5.6.3.3 Market size and forecast, by Application
8.5.6.3.4 Market size and forecast, by Distribution Channel
CHAPTER 9: COMPANY LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments
CHAPTER 10: COMPANY PROFILES
10.1 Dabur India Ltd
10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Operating business segments
10.1.4 Product portfolio
10.1.5 Business performance
10.1.6 Key strategic moves and developments
10.2 Emami Limited
10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Operating business segments
10.2.4 Product portfolio
10.2.5 Business performance
10.2.6 Key strategic moves and developments
10.3 kairali ayurvedic group
10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Operating business segments
10.3.4 Product portfolio
10.3.5 Business performance
10.3.6 Key strategic moves and developments
10.4 Himalaya Wellness
10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Operating business segments
10.4.4 Product portfolio
10.4.5 Business performance
10.4.6 Key strategic moves and developments
10.5 Colgate-Palmolive Company
10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Operating business segments
10.5.4 Product portfolio
10.5.5 Business performance
10.5.6 Key strategic moves and developments
10.6 Procter & Gamble
10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Operating business segments
10.6.4 Product portfolio
10.6.5 Business performance
10.6.6 Key strategic moves and developments
10.7 Patanjali Ayurved Limited
10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Operating business segments
10.7.4 Product portfolio
10.7.5 Business performance
10.7.6 Key strategic moves and developments
10.8 Shahnaz Ayurveda Pvt. Ltd.
10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Operating business segments
10.8.4 Product portfolio
10.8.5 Business performance
10.8.6 Key strategic moves and developments
10.9 Shree Baidyanath Ayurveda Bhawan Pvt. Ltd
10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Operating business segments
10.9.4 Product portfolio
10.9.5 Business performance
10.9.6 Key strategic moves and developments
10.10 Unilever
10.10.1 Company overview
10.10.2 Company snapshot
10.10.3 Operating business segments
10.10.4 Product portfolio
10.10.5 Business performance
10.10.6 Key strategic moves and developments
10.11 ENOMARK BIOTECH (ENOMARK HEALTHCARE)
10.11.1 Company overview
10.11.2 Company snapshot
10.11.3 Operating business segments
10.11.4 Product portfolio
10.11.5 Business performance
10.11.6 Key strategic moves and developments
10.12 Riaan Wellness Pvt. Ltd.
10.12.1 Company overview
10.12.2 Company snapshot
10.12.3 Operating business segments
10.12.4 Product portfolio
10.12.5 Business performance
10.12.6 Key strategic moves and developments
10.13 .Givaudan International SA (NATUREX S.A.)
10.13.1 Company overview
10.13.2 Company snapshot
10.13.3 Operating business segments
10.13.4 Product portfolio
10.13.5 Business performance
10.13.6 Key strategic moves and developments
10.14 PLT Health Solutions
10.14.1 Company overview
10.14.2 Company snapshot
10.14.3 Operating business segments
10.14.4 Product portfolio
10.14.5 Business performance
10.14.6 Key strategic moves and developments
10.15 INDENA S.P.A
10.15.1 Company overview
10.15.2 Company snapshot
10.15.3 Operating business segments
10.15.4 Product portfolio
10.15.5 Business performance
10.15.6 Key strategic moves and developments
TABLE 1. GLOBAL ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 2. ADAPTOGENS MARKET, FOR ASHWAGANDHA, BY REGION, 2021-2031 ($MILLION)
TABLE 3. ADAPTOGENS MARKET FOR ASHWAGANDHA, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. ADAPTOGENS MARKET, FOR GINSENG, BY REGION, 2021-2031 ($MILLION)
TABLE 5. ADAPTOGENS MARKET FOR GINSENG, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 6. ADAPTOGENS MARKET, FOR ASTRAGALUS, BY REGION, 2021-2031 ($MILLION)
TABLE 7. ADAPTOGENS MARKET FOR ASTRAGALUS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 8. ADAPTOGENS MARKET, FOR HOLY BASILS, BY REGION, 2021-2031 ($MILLION)
TABLE 9. ADAPTOGENS MARKET FOR HOLY BASILS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 10. ADAPTOGENS MARKET, FOR RHODIOLA ROSEAS, BY REGION, 2021-2031 ($MILLION)
TABLE 11. ADAPTOGENS MARKET FOR RHODIOLA ROSEAS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 12. ADAPTOGENS MARKET, FOR SCHISANDRA, BY REGION, 2021-2031 ($MILLION)
TABLE 13. ADAPTOGENS MARKET FOR SCHISANDRA, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 14. ADAPTOGENS MARKET, FOR ADAPTOGENIC MUSHROOMS, BY REGION, 2021-2031 ($MILLION)
TABLE 15. ADAPTOGENS MARKET FOR ADAPTOGENIC MUSHROOMS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 16. ADAPTOGENS MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 17. ADAPTOGENS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 18. GLOBAL ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 19. ADAPTOGENS MARKET, FOR POWDER, BY REGION, 2021-2031 ($MILLION)
TABLE 20. ADAPTOGENS MARKET FOR POWDER, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 21. ADAPTOGENS MARKET, FOR CAPSULES, BY REGION, 2021-2031 ($MILLION)
TABLE 22. ADAPTOGENS MARKET FOR CAPSULES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 23. ADAPTOGENS MARKET, FOR TEAS AND BEVERAGES, BY REGION, 2021-2031 ($MILLION)
TABLE 24. ADAPTOGENS MARKET FOR TEAS AND BEVERAGES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 25. ADAPTOGENS MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 26. ADAPTOGENS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 27. GLOBAL ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 28. ADAPTOGENS MARKET, FOR FOOD AND BEVERAGES, BY REGION, 2021-2031 ($MILLION)
TABLE 29. ADAPTOGENS MARKET FOR FOOD AND BEVERAGES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 30. ADAPTOGENS MARKET, FOR DIETARY AND SPORTS SUPPLEMENTS, BY REGION, 2021-2031 ($MILLION)
TABLE 31. ADAPTOGENS MARKET FOR DIETARY AND SPORTS SUPPLEMENTS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 32. ADAPTOGENS MARKET, FOR COSMETICS, BY REGION, 2021-2031 ($MILLION)
TABLE 33. ADAPTOGENS MARKET FOR COSMETICS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 34. ADAPTOGENS MARKET, FOR ANIMAL FEED, BY REGION, 2021-2031 ($MILLION)
TABLE 35. ADAPTOGENS MARKET FOR ANIMAL FEED, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 36. ADAPTOGENS MARKET, FOR PHARMACEUTICAL, BY REGION, 2021-2031 ($MILLION)
TABLE 37. ADAPTOGENS MARKET FOR PHARMACEUTICAL, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 38. GLOBAL ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 39. ADAPTOGENS MARKET, FOR BUSINESS TO BUSINESS, BY REGION, 2021-2031 ($MILLION)
TABLE 40. ADAPTOGENS MARKET FOR BUSINESS TO BUSINESS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 41. ADAPTOGENS MARKET, FOR BUSINESS TO CONSUMER, BY REGION, 2021-2031 ($MILLION)
TABLE 42. ADAPTOGENS MARKET FOR BUSINESS TO CONSUMER, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 43. GLOBAL BUSINESS TO CONSUMER ADAPTOGENS MARKET, BY SALES CHANNEL, 2021-2031 ($MILLION)
TABLE 44. ADAPTOGENS MARKET, FOR SUPERMARKET AND HYPERMARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 45. ADAPTOGENS MARKET, FOR SPECIALTY STORE, BY REGION, 2021-2031 ($MILLION)
TABLE 46. ADAPTOGENS MARKET, FOR PHARMACIES AND DRUG STORES, BY REGION, 2021-2031 ($MILLION)
TABLE 47. ADAPTOGENS MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 48. ADAPTOGENS MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 49. NORTH AMERICA ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 50. NORTH AMERICA ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 51. NORTH AMERICA ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 52. NORTH AMERICA ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 53. NORTH AMERICA BUSINESS TO CONSUMER ADAPTOGENS MARKET, BY SALES CHANNEL, 2021-2031 ($MILLION)
TABLE 54. NORTH AMERICA ADAPTOGENS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 55. U.S. ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 56. U.S. ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 57. U.S. ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 58. U.S. ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 59. CANADA ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 60. CANADA ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 61. CANADA ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 62. CANADA ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 63. MEXICO ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 64. MEXICO ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 65. MEXICO ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 66. MEXICO ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 67. EUROPE ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 68. EUROPE ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 69. EUROPE ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 70. EUROPE ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 71. EUROPE BUSINESS TO CONSUMER ADAPTOGENS MARKET, BY SALES CHANNEL, 2021-2031 ($MILLION)
TABLE 72. EUROPE ADAPTOGENS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 73. UK ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 74. UK ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 75. UK ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 76. UK ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 77. ITALY ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 78. ITALY ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 79. ITALY ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 80. ITALY ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 81. GERMANY ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 82. GERMANY ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 83. GERMANY ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 84. GERMANY ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 85. FRANCE ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 86. FRANCE ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 87. FRANCE ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 88. FRANCE ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 89. SPAIN ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 90. SPAIN ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 91. SPAIN ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 92. SPAIN ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 93. THE NETHERLANDS ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 94. THE NETHERLANDS ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 95. THE NETHERLANDS ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 96. THE NETHERLANDS ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 97. SWITZERLAND ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 98. SWITZERLAND ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 99. SWITZERLAND ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 100. SWITZERLAND ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 101. REST OF EUROPE ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 102. REST OF EUROPE ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 103. REST OF EUROPE ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 104. REST OF EUROPE ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 105. ASIA-PACIFIC ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 106. ASIA-PACIFIC ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 107. ASIA-PACIFIC ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 108. ASIA-PACIFIC ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 109. ASIA-PACIFIC BUSINESS TO CONSUMER ADAPTOGENS MARKET, BY SALES CHANNEL, 2021-2031 ($MILLION)
TABLE 110. ASIA-PACIFIC ADAPTOGENS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 111. CHINA ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 112. CHINA ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 113. CHINA ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 114. CHINA ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 115. JAPAN ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 116. JAPAN ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 117. JAPAN ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 118. JAPAN ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 119. INDIA ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 120. INDIA ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 121. INDIA ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 122. INDIA ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 123. SOUTH KOREA ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 124. SOUTH KOREA ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 125. SOUTH KOREA ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 126. SOUTH KOREA ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 127. AUSTRALIA ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 128. AUSTRALIA ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 129. AUSTRALIA ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 130. AUSTRALIA ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 131. INDONESIA ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 132. INDONESIA ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 133. INDONESIA ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 134. INDONESIA ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 135. THAILAND ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 136. THAILAND ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 137. THAILAND ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 138. THAILAND ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 139. REST OF ASIA-PACIFIC ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 140. REST OF ASIA-PACIFIC ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 141. REST OF ASIA-PACIFIC ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 142. REST OF ASIA-PACIFIC ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 143. LAMEA ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 144. LAMEA ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 145. LAMEA ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 146. LAMEA ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 147. LAMEA BUSINESS TO CONSUMER ADAPTOGENS MARKET, BY SALES CHANNEL, 2021-2031 ($MILLION)
TABLE 148. LAMEA ADAPTOGENS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 149. LATIN AMERICA ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 150. LATIN AMERICA ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 151. LATIN AMERICA ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 152. LATIN AMERICA ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 153. MIDDLE EAST ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 154. MIDDLE EAST ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 155. MIDDLE EAST ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 156. MIDDLE EAST ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 157. AFRICA ADAPTOGENS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 158. AFRICA ADAPTOGENS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 159. AFRICA ADAPTOGENS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 160. AFRICA ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 161.DABUR INDIA LTD: COMPANY SNAPSHOT
TABLE 162.DABUR INDIA LTD: OPERATING SEGMENTS
TABLE 163.DABUR INDIA LTD: PRODUCT PORTFOLIO
TABLE 164.DABUR INDIA LTD: NET SALES,
TABLE 165.DABUR INDIA LTD: KEY STRATERGIES
TABLE 166.EMAMI LIMITED: COMPANY SNAPSHOT
TABLE 167.EMAMI LIMITED: OPERATING SEGMENTS
TABLE 168.EMAMI LIMITED: PRODUCT PORTFOLIO
TABLE 169.EMAMI LIMITED: NET SALES,
TABLE 170.EMAMI LIMITED: KEY STRATERGIES
TABLE 171.KAIRALI AYURVEDIC GROUP: COMPANY SNAPSHOT
TABLE 172.KAIRALI AYURVEDIC GROUP: OPERATING SEGMENTS
TABLE 173.KAIRALI AYURVEDIC GROUP: PRODUCT PORTFOLIO
TABLE 174.KAIRALI AYURVEDIC GROUP: NET SALES,
TABLE 175.KAIRALI AYURVEDIC GROUP: KEY STRATERGIES
TABLE 176.HIMALAYA WELLNESS: COMPANY SNAPSHOT
TABLE 177.HIMALAYA WELLNESS: OPERATING SEGMENTS
TABLE 178.HIMALAYA WELLNESS: PRODUCT PORTFOLIO
TABLE 179.HIMALAYA WELLNESS: NET SALES,
TABLE 180.HIMALAYA WELLNESS: KEY STRATERGIES
TABLE 181.COLGATE-PALMOLIVE COMPANY: COMPANY SNAPSHOT
TABLE 182.COLGATE-PALMOLIVE COMPANY: OPERATING SEGMENTS
TABLE 183.COLGATE-PALMOLIVE COMPANY: PRODUCT PORTFOLIO
TABLE 184.COLGATE-PALMOLIVE COMPANY: NET SALES,
TABLE 185.COLGATE-PALMOLIVE COMPANY: KEY STRATERGIES
TABLE 186.PROCTER & GAMBLE: COMPANY SNAPSHOT
TABLE 187.PROCTER & GAMBLE: OPERATING SEGMENTS
TABLE 188.PROCTER & GAMBLE: PRODUCT PORTFOLIO
TABLE 189.PROCTER & GAMBLE: NET SALES,
TABLE 190.PROCTER & GAMBLE: KEY STRATERGIES
TABLE 191.PATANJALI AYURVED LIMITED: COMPANY SNAPSHOT
TABLE 192.PATANJALI AYURVED LIMITED: OPERATING SEGMENTS
TABLE 193.PATANJALI AYURVED LIMITED: PRODUCT PORTFOLIO
TABLE 194.PATANJALI AYURVED LIMITED: NET SALES,
TABLE 195.PATANJALI AYURVED LIMITED: KEY STRATERGIES
TABLE 196.SHAHNAZ AYURVEDA PVT. LTD.: COMPANY SNAPSHOT
TABLE 197.SHAHNAZ AYURVEDA PVT. LTD.: OPERATING SEGMENTS
TABLE 198.SHAHNAZ AYURVEDA PVT. LTD.: PRODUCT PORTFOLIO
TABLE 199.SHAHNAZ AYURVEDA PVT. LTD.: NET SALES,
TABLE 200.SHAHNAZ AYURVEDA PVT. LTD.: KEY STRATERGIES
TABLE 201.SHREE BAIDYANATH AYURVEDA BHAWAN PVT. LTD: COMPANY SNAPSHOT
TABLE 202.SHREE BAIDYANATH AYURVEDA BHAWAN PVT. LTD: OPERATING SEGMENTS
TABLE 203.SHREE BAIDYANATH AYURVEDA BHAWAN PVT. LTD: PRODUCT PORTFOLIO
TABLE 204.SHREE BAIDYANATH AYURVEDA BHAWAN PVT. LTD: NET SALES,
TABLE 205.SHREE BAIDYANATH AYURVEDA BHAWAN PVT. LTD: KEY STRATERGIES
TABLE 206.UNILEVER: COMPANY SNAPSHOT
TABLE 207.UNILEVER: OPERATING SEGMENTS
TABLE 208.UNILEVER: PRODUCT PORTFOLIO
TABLE 209.UNILEVER: NET SALES,
TABLE 210.UNILEVER: KEY STRATERGIES
TABLE 211.ENOMARK BIOTECH (ENOMARK HEALTHCARE): COMPANY SNAPSHOT
TABLE 212.ENOMARK BIOTECH (ENOMARK HEALTHCARE): OPERATING SEGMENTS
TABLE 213.ENOMARK BIOTECH (ENOMARK HEALTHCARE): PRODUCT PORTFOLIO
TABLE 214.ENOMARK BIOTECH (ENOMARK HEALTHCARE): NET SALES,
TABLE 215.ENOMARK BIOTECH (ENOMARK HEALTHCARE): KEY STRATERGIES
TABLE 216.RIAAN WELLNESS PVT. LTD.: COMPANY SNAPSHOT
TABLE 217.RIAAN WELLNESS PVT. LTD.: OPERATING SEGMENTS
TABLE 218.RIAAN WELLNESS PVT. LTD.: PRODUCT PORTFOLIO
TABLE 219.RIAAN WELLNESS PVT. LTD.: NET SALES,
TABLE 220.RIAAN WELLNESS PVT. LTD.: KEY STRATERGIES
TABLE 221..GIVAUDAN INTERNATIONAL SA (NATUREX S.A.): COMPANY SNAPSHOT
TABLE 222..GIVAUDAN INTERNATIONAL SA (NATUREX S.A.): OPERATING SEGMENTS
TABLE 223..GIVAUDAN INTERNATIONAL SA (NATUREX S.A.): PRODUCT PORTFOLIO
TABLE 224..GIVAUDAN INTERNATIONAL SA (NATUREX S.A.): NET SALES,
TABLE 225..GIVAUDAN INTERNATIONAL SA (NATUREX S.A.): KEY STRATERGIES
TABLE 226.PLT HEALTH SOLUTIONS: COMPANY SNAPSHOT
TABLE 227.PLT HEALTH SOLUTIONS: OPERATING SEGMENTS
TABLE 228.PLT HEALTH SOLUTIONS: PRODUCT PORTFOLIO
TABLE 229.PLT HEALTH SOLUTIONS: NET SALES,
TABLE 230.PLT HEALTH SOLUTIONS: KEY STRATERGIES
TABLE 231.INDENA S.P.A: COMPANY SNAPSHOT
TABLE 232.INDENA S.P.A: OPERATING SEGMENTS
TABLE 233.INDENA S.P.A: PRODUCT PORTFOLIO
TABLE 234.INDENA S.P.A: NET SALES,
TABLE 235.INDENA S.P.A: KEY STRATERGIES
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
